Sildenafil-mediated acute cardioprotection is independent of the NO/cGMP pathway. (Q53589410)

16 May 2018

title

Sildenafil-mediated acute cardioprotection is independent of the NO/cGMP pathway. (English)

1 reference

16 May 2018

author

John W. Elrod

series ordinal

1

1 reference

16 May 2018

author name string

James J M Greer

series ordinal

2

1 reference

16 May 2018

David J Lefer

series ordinal

3

1 reference

16 May 2018

publication date

1 September 2006

1 reference

16 May 2018

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

16 May 2018

volume

292

1 reference

16 May 2018

issue

1

1 reference

16 May 2018

page(s)

H342-7

1 reference

16 May 2018

Mechanism of cGMP-mediated protection in a cellular model of myocardial reperfusion injury

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Compartmentalization of NO signaling cascade in skeletal muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Protein kinase C plays an essential role in sildenafil-induced cardioprotection in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Myocardial infarction and heart failure in the db/db diabetic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Sildenafil citrate increases myocardial cGMP content in rat heart, decreases its hypertrophic response to isoproterenol and decreases myocardial leak of creatine kinase and troponin T

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Pretreatment with simvastatin attenuates myocardial dysfunction after ischemia and chronic reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Role of cyclic guanosine monophosphate in late preconditioning in conscious rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Cardioprotection with phosphodiesterase-5 inhibition--a novel preconditioning strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Application of pharmaceuticals to nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Exogenous NO triggers preconditioning via a cGMP- and mitoKATP-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Effects of sildenafil on myocardial infarct size, microvascular function, and acute ischemic left ventricular dilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Congestive heart failure in the diabetic

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00306.2006

10.1152/AJPHEART.00306.2006

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

PubMed ID

16951048

1 reference

16 May 2018